annual CFI:
-$270.00K+$312.00K(+53.61%)Summary
- As of today (May 30, 2025), AXSM annual cash flow from investing activities is -$270.00 thousand, with the most recent change of +$312.00 thousand (+53.61%) on December 31, 2024.
- During the last 3 years, AXSM annual CFI has risen by +$38.00 thousand (+12.34%).
- AXSM annual CFI is now -2627.27% below its all-time high of -$9900.00, reached on December 31, 2017.
Performance
AXSM Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$338.00K-$308.00K(-1026.67%)Summary
- As of today (May 30, 2025), AXSM quarterly cash flow from investing activities is -$338.00 thousand, with the most recent change of -$308.00 thousand (-1026.67%) on March 31, 2025.
- Over the past year, AXSM quarterly CFI has dropped by -$240.00 thousand (-244.90%).
Performance
AXSM quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$510.00K-$240.00K(-88.89%)Summary
- As of today (May 30, 2025), AXSM TTM cash flow from investing activities is -$510.00 thousand, with the most recent change of -$240.00 thousand (-88.89%) on March 31, 2025.
- Over the past year, AXSM TTM CFI has increased by +$99.00 thousand (+16.26%).
- AXSM TTM CFI is now -5051.52% below its all-time high of -$9900.00, reached on December 31, 2017.
Performance
AXSM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AXSM Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +53.6% | -244.9% | +16.3% |
| 3 y3 years | +12.3% | -57.9% | -3.6% |
| 5 y5 years | -1577.0% | -3534.4% | -1900.0% |
AXSM Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.5% | -4728.6% | +99.4% | -106.5% | +99.0% |
| 5 y | 5-year | -1577.0% | +99.5% | <-9999.0% | +99.4% | -3211.7% | +99.0% |
| alltime | all time | -2627.3% | +99.5% | <-9999.0% | +99.4% | -5051.5% | +99.0% |
AXSM Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$338.00K(+1026.7%) | -$510.00K(+88.9%) |
| Dec 2024 | -$270.00K(-53.6%) | -$30.00K(-66.7%) | -$270.00K(+9.3%) |
| Sep 2024 | - | -$90.00K(+73.1%) | -$247.00K(-53.2%) |
| Jun 2024 | - | -$52.00K(-46.9%) | -$528.00K(-13.3%) |
| Mar 2024 | - | -$98.00K(+1300.0%) | -$609.00K(+4.6%) |
| Dec 2023 | -$582.00K(-98.9%) | -$7000.00(-98.1%) | -$582.00K(-23.0%) |
| Sep 2023 | - | -$371.00K(+178.9%) | -$756.00K(+67.6%) |
| Jun 2023 | - | -$133.00K(+87.3%) | -$451.00K(-99.2%) |
| Mar 2023 | - | -$71.00K(-60.8%) | -$53.56M(-0.3%) |
| Dec 2022 | -$53.70M(>+9900.0%) | -$181.00K(+174.2%) | -$53.70M(+0.3%) |
| Sep 2022 | - | -$66.00K(-99.9%) | -$53.52M(-0.4%) |
| Jun 2022 | - | -$53.24M(>+9900.0%) | -$53.71M(>+9900.0%) |
| Mar 2022 | - | -$214.00K(>+9900.0%) | -$492.10K(+59.7%) |
| Dec 2021 | -$308.00K(+571.0%) | -$500.00(-99.8%) | -$308.10K(-6.0%) |
| Sep 2021 | - | -$258.70K(+1268.8%) | -$327.90K(+290.4%) |
| Jun 2021 | - | -$18.90K(-37.0%) | -$84.00K(+26.3%) |
| Mar 2021 | - | -$30.00K(+47.8%) | -$66.50K(+45.2%) |
| Dec 2020 | -$45.90K | -$20.30K(+37.2%) | -$45.80K(+69.6%) |
| Sep 2020 | - | -$14.80K(+957.1%) | -$27.00K(+75.3%) |
| Jun 2020 | - | -$1400.00(-84.9%) | -$15.40K(-39.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$9300.00(+520.0%) | -$25.50K(+57.4%) |
| Dec 2019 | -$16.10K(-50.8%) | -$1500.00(-53.1%) | -$16.20K(+10.2%) |
| Sep 2019 | - | -$3200.00(-72.2%) | -$14.70K(-26.5%) |
| Jun 2019 | - | -$11.50K(<-9900.0%) | -$20.00K(+10.5%) |
| Mar 2019 | - | $0.00(0.0%) | -$18.10K(-44.6%) |
| Dec 2018 | -$32.70K(+230.3%) | $0.00(-100.0%) | -$32.70K(0.0%) |
| Sep 2018 | - | -$8500.00(-11.5%) | -$32.70K(+17.6%) |
| Jun 2018 | - | -$9600.00(-34.2%) | -$27.80K(+28.7%) |
| Mar 2018 | - | -$14.60K(<-9900.0%) | -$21.60K(+118.2%) |
| Dec 2017 | -$9900.00(-90.5%) | $0.00(-100.0%) | -$9900.00(-38.1%) |
| Sep 2017 | - | -$3600.00(+5.9%) | -$16.00K(-82.0%) |
| Jun 2017 | - | -$3400.00(+17.2%) | -$88.70K(-8.5%) |
| Mar 2017 | - | -$2900.00(-52.5%) | -$96.90K(-7.4%) |
| Dec 2016 | -$104.60K(+417.8%) | -$6100.00(-92.0%) | -$104.70K(+1.9%) |
| Sep 2016 | - | -$76.30K(+557.8%) | -$102.70K(+233.4%) |
| Jun 2016 | - | -$11.60K(+8.4%) | -$30.80K(+49.5%) |
| Mar 2016 | - | -$10.70K(+161.0%) | -$20.60K(+2.0%) |
| Dec 2015 | -$20.20K | -$4100.00(-6.8%) | -$20.20K(+25.5%) |
| Sep 2015 | - | -$4400.00(+214.3%) | -$16.10K(+37.6%) |
| Jun 2015 | - | -$1400.00(-86.4%) | -$11.70K(+13.6%) |
| Mar 2015 | - | -$10.30K | -$10.30K |
FAQ
- What is Axsome Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Axsome Therapeutics?
- What is Axsome Therapeutics annual CFI year-on-year change?
- What is Axsome Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly CFI year-on-year change?
- What is Axsome Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Axsome Therapeutics?
- What is Axsome Therapeutics TTM CFI year-on-year change?
What is Axsome Therapeutics annual cash flow from investing activities?
The current annual CFI of AXSM is -$270.00K
What is the all time high annual CFI for Axsome Therapeutics?
Axsome Therapeutics all-time high annual cash flow from investing activities is -$9900.00
What is Axsome Therapeutics annual CFI year-on-year change?
Over the past year, AXSM annual cash flow from investing activities has changed by +$312.00K (+53.61%)
What is Axsome Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of AXSM is -$338.00K
What is the all time high quarterly CFI for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly cash flow from investing activities is $0.00
What is Axsome Therapeutics quarterly CFI year-on-year change?
Over the past year, AXSM quarterly cash flow from investing activities has changed by -$240.00K (-244.90%)
What is Axsome Therapeutics TTM cash flow from investing activities?
The current TTM CFI of AXSM is -$510.00K
What is the all time high TTM CFI for Axsome Therapeutics?
Axsome Therapeutics all-time high TTM cash flow from investing activities is -$9900.00
What is Axsome Therapeutics TTM CFI year-on-year change?
Over the past year, AXSM TTM cash flow from investing activities has changed by +$99.00K (+16.26%)